Valuation: Sysmex Corporation

Market Cap 1,112B 7.02B 6.26B 5.8B 5.27B 9.89B 666B 10.05B 69.53B 27.34B 348B 26.34B 25.79B P/E 2027 *
27.8x
P/E 2028 * 22.6x
Enterprise Value 1,133B 7.15B 6.38B 5.91B 5.37B 10.08B 678B 10.24B 70.85B 27.86B 354B 26.84B 26.28B EV / Sales 2027 *
2.07x
EV / Sales 2028 * 1.96x
Free-Float
71.34%
Yield 2027 *
2.19%
Yield 2028 * 2.28%
1 day+0.38%
1 week-1.34%
Current month-0.03%
1 month-0.51%
3 months+15.14%
6 months+28.31%
Current year+19.58%
1 week 1,807.5
Extreme 1807.5
1,868.5
1 month 1,807.5
Extreme 1807.5
1,917
Current year 1,246
Extreme 1246
2,012.5
1 year 1,246
Extreme 1246
2,012.5
3 years 1,246
Extreme 1246
3,236
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 77 2018-03-31
Director of Finance/CFO 56 -
President 65 2026-03-31
Director TitleAgeSince
Chairman 77 2013-03-31
Director/Board Member 65 2019-05-31
Director/Board Member 71 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%-1.34%+1.26%-21.58% 7.1B
-0.79%+2.20%-19.04%+9.03% 181B
-2.09%+0.91%-3.14%+28.22% 116B
+1.11%+5.43%-20.43%+11.00% 113B
-1.52%+3.61%-51.34%-6.22% 79.83B
-0.27%+4.60%+4.72%+79.05% 65.06B
+0.02%+1.07%+13.28%+75.06% 54.35B
-0.53%+0.98%+0.87%-25.92% 52.23B
-0.81%+6.08%-12.53%+30.57% 44.15B
-0.07%+0.07%+29.10%-0.07% 32.47B
Average -0.46%+2.68%-5.73%+17.91% 74.57B
Weighted average by Cap. -0.62%+2.95%-11.74%+19.74%

Financials

2027 *2028 *
Net sales 549B 3.46B 3.09B 2.86B 2.6B 4.88B 328B 4.96B 34.3B 13.49B 172B 12.99B 12.72B 577B 3.65B 3.25B 3.01B 2.74B 5.14B 346B 5.22B 36.11B 14.2B 181B 13.68B 13.39B
Net income 40.33B 255M 227M 210M 191M 359M 24.14B 365M 2.52B 992M 12.62B 955M 935M 49.41B 312M 278M 258M 234M 439M 29.57B 447M 3.09B 1.21B 15.46B 1.17B 1.15B
Net Debt 21.13B 133M 119M 110M 100M 188M 12.65B 191M 1.32B 520M 6.61B 500M 490M 20.46B 129M 115M 107M 96.95M 182M 12.24B 185M 1.28B 503M 6.4B 484M 474M
Projected Income Statement - Annual - Sysmex Corporation
Logo Sysmex Corporation
SYSMEX CORPORATION is a Japan-based company engaged in the development, manufacture, sale, servicing and import/export of clinical testing instruments and reagents for the medical field. It proposes solutions to address the diverse challenges faced by medical institutions by integrating a wide range of products and services, including software, maintenance for clinical testing equipment, and academic support. It operates business through four segments centered on regional controlling entity, including Headquarters, Americas, Europe, Middle East and Africa (EMEA), China and Asia-Pacific (AP). Headquarters segment operates with the Company itself acting as the controlling entity, responsible for product development, manufacture and others, consolidated subsidiaries within this segment handle the development and manufacturing of certain products, as well as domestic and overseas sales. Americas, Europe, EMEA, China and AP segments operate business in their respective regions.
Employees
10,861
Date Price Change Volume
26-10-19 ¥1,845.00 +0.41% 1,045,600
26-10-19 ¥1,837.50 -0.84% 3,017,000
26-10-16 ¥1,853.00 +0.65% 5,418,400
26-10-15 ¥1,841.00 +0.63% 4,124,800
26-10-14 ¥1,829.50 -2.14% 2,865,500
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Sysmex Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,837.50JPY
Average target price
2,139.29JPY
Spread / Average Target
+16.42%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sysmex Corporation
  1. Stock Market
  2. Stocks
  3. 6869 Stock